122 related articles for article (PubMed ID: 32776998)
21. Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward.
Black E; Richmond R
Global Health; 2019 Jan; 15(1):3. PubMed ID: 30621753
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer subtype and screening sensitivity in the Quebec Mammography Screening Program.
Perron L; Chang SL; Daigle JM; Vandal N; Theberge I; Diorio C; Lemieux J; Pelletier E; Brisson J
J Med Screen; 2019 Sep; 26(3):154-161. PubMed ID: 30572782
[No Abstract] [Full Text] [Related]
24. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness Analysis of a Mobile Mammography Unit for Breast Cancer Screening to Reduce Geographic and Social Health Inequalities.
De Mil R; Guillaume E; Launay L; Guittet L; Dejardin O; Bouvier V; Notari A; Launoy G; Berchi C
Value Health; 2019 Oct; 22(10):1111-1118. PubMed ID: 31563253
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer in Mexico: a growing challenge to health and the health system.
Chávarri-Guerra Y; Villarreal-Garza C; Liedke PE; Knaul F; Mohar A; Finkelstein DM; Goss PE
Lancet Oncol; 2012 Aug; 13(8):e335-43. PubMed ID: 22846838
[TBL] [Abstract][Full Text] [Related]
27. Modes of Early Detection of Breast Cancer in Katowice Region, Poland.
Zejda JE; Kaleta A
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32290585
[TBL] [Abstract][Full Text] [Related]
28. Hospitalized women's willingness to pay for an inpatient screening mammogram.
Khaliq W; Harris CM; Landis R; Bridges JF; Wright SM
Ann Fam Med; 2014; 12(6):556-8. PubMed ID: 25384819
[TBL] [Abstract][Full Text] [Related]
29. The cost-effectiveness of digital breast tomosynthesis in a population breast cancer screening program.
Wang J; Phi XA; Greuter MJW; Daszczuk AM; Feenstra TL; Pijnappel RM; Vermeulen KM; Buls N; Houssami N; Lu W; de Bock GH
Eur Radiol; 2020 Oct; 30(10):5437-5445. PubMed ID: 32382844
[TBL] [Abstract][Full Text] [Related]
30. Retrospective observation on contribution and limitations of screening for breast cancer with mammography in Korea: detection rate of breast cancer and incidence rate of interval cancer of the breast.
Lee K; Kim H; Lee JH; Jeong H; Shin SA; Han T; Seo YL; Yoo Y; Nam SE; Park JH; Park YM
BMC Womens Health; 2016 Nov; 16(1):72. PubMed ID: 27863517
[TBL] [Abstract][Full Text] [Related]
31. Screening Mammography Program of British Columbia: pattern of use and health care system costs.
Olivotto IA; Kan L; Mates D; King S
CMAJ; 1999 Feb; 160(3):337-41. PubMed ID: 10065075
[TBL] [Abstract][Full Text] [Related]
32. Cost implications of routine mammography screening of women 50-69 years in the county of Funen, Denmark.
Bech M; Gyrd-Hansen D
Health Policy; 2000 Nov; 54(2):125-41. PubMed ID: 11094266
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer screening: Does tomosynthesis augment mammography?
Takahashi TA; Lee CI; Johnson KM
Cleve Clin J Med; 2017 Jul; 84(7):522-527. PubMed ID: 28696192
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer screening controversies: who, when, why, and how?
Chetlen A; Mack J; Chan T
Clin Imaging; 2016; 40(2):279-82. PubMed ID: 26093511
[TBL] [Abstract][Full Text] [Related]
35. Screening Mammography: Recommendations and Controversies.
Witten M; Parker CC
Surg Clin North Am; 2018 Aug; 98(4):667-675. PubMed ID: 30005766
[TBL] [Abstract][Full Text] [Related]
36. Expansion of screening mammography in the Veterans Health Administration: implications for breast cancer treatment.
Kvasnovsky CL; Kesmodel SB; Gragasin JL; Punnoose V; Johnson PA; Goel R; Reddy SK; Pierson RN; Jain A
JAMA Surg; 2013 Nov; 148(11):999-1004. PubMed ID: 24048217
[TBL] [Abstract][Full Text] [Related]
37. National expenditure for false-positive mammograms and breast cancer overdiagnoses estimated at $4 billion a year.
Ong MS; Mandl KD
Health Aff (Millwood); 2015 Apr; 34(4):576-83. PubMed ID: 25847639
[TBL] [Abstract][Full Text] [Related]
38. Reform of the National Screening Mammography Program in France.
Barratt A; Jørgensen KJ; Autier P
JAMA Intern Med; 2018 Feb; 178(2):177-178. PubMed ID: 29084317
[No Abstract] [Full Text] [Related]
39. [Recent controversies over mammography screening].
Hinneburg I
Med Monatsschr Pharm; 2014 Aug; 37(8):280-3. PubMed ID: 25158376
[TBL] [Abstract][Full Text] [Related]
40. Mammography is the most effective method of breast cancer screening.
Islam SR; Aziz SM
Mymensingh Med J; 2012 Apr; 21(2):366-71. PubMed ID: 22561789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
